- Home
- EVGR vs AVTX Comparison
EVGR vs AVTX Comparison
Compare EVGR & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGR
- AVTX
- Stock Information
- Founded
- EVGR 2021
- AVTX 2011
- Country
- EVGR Malaysia
- AVTX United States
- Employees
- EVGR N/A
- AVTX N/A
- Industry
- EVGR Blank Checks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EVGR Finance
- AVTX Health Care
- Exchange
- EVGR Nasdaq
- AVTX Nasdaq
- Market Cap
- EVGR 94.7M
- AVTX 90.9M
- IPO Year
- EVGR 2022
- AVTX 2015
- Fundamental
- Price
- EVGR $11.75
- AVTX $12.58
- Analyst Decision
- EVGR
- AVTX Buy
- Analyst Count
- EVGR 0
- AVTX 2
- Target Price
- EVGR N/A
- AVTX $35.00
- AVG Volume (30 Days)
- EVGR 1.5K
- AVTX 64.4K
- Earning Date
- EVGR 10-10-2024
- AVTX 11-07-2024
- Dividend Yield
- EVGR N/A
- AVTX N/A
- EPS Growth
- EVGR 3.29
- AVTX N/A
- EPS
- EVGR 0.28
- AVTX N/A
- Revenue
- EVGR N/A
- AVTX $820,000.00
- Revenue This Year
- EVGR N/A
- AVTX N/A
- Revenue Next Year
- EVGR N/A
- AVTX N/A
- P/E Ratio
- EVGR $42.22
- AVTX N/A
- Revenue Growth
- EVGR N/A
- AVTX N/A
- 52 Week Low
- EVGR $11.05
- AVTX $3.95
- 52 Week High
- EVGR $11.79
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- EVGR 51.96
- AVTX 52.17
- Support Level
- EVGR $11.73
- AVTX $12.00
- Resistance Level
- EVGR $11.78
- AVTX $13.59
- Average True Range (ATR)
- EVGR 0.00
- AVTX 0.96
- MACD
- EVGR -0.01
- AVTX -0.15
- Stochastic Oscillator
- EVGR 40.00
- AVTX 33.52
About EVGR Evergreen Corporation
Evergreen Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).